Photo courtesy of GACI Global

Rare Community Profiles: Creating a Strong Patient Advocacy-Pharma Partnership: How Inozyme Pharma and GACI Global Came Together for Impact

• Post author:Jessica Lynn
• Post published:December 6, 2023
• Post category:Generalized arterial calcification of infancy-1 (GACI1)

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: Creating a Strong Patient Advocacy-Pharma Partnership: How Inozyme Pharma and GACI Global Came Together for Impact

source: shutterstock.com

World Orphan Drug Congress USA 2023: Inozyme HCP and Patient Engagement Executive Discuss Importance of Technology and Partnerships in Rare Disease Diagnosis and Treatment

• Post author:James Moore
• Post published:June 22, 2023
• Post category:ABCC6 deficiency/ENPP1 Deficiency/Generalized arterial calcification of infancy-1 (GACI1)/Pseudoxanthoma elasticum

The World Orphan Drug Congress USA 2023 was held from May 23-25, 2023, at the Gaylord National Resort & Convention Center in National Harbor, MD. This conference is focused solely…

Continue Reading World Orphan Drug Congress USA 2023: Inozyme HCP and Patient Engagement Executive Discuss Importance of Technology and Partnerships in Rare Disease Diagnosis and Treatment

source: pixabay.com

GACI/ARHR2 Awareness Day is February 1st: Spreading rare Disease Awareness

• Post author:James Moore
• Post published:January 26, 2023
• Post category:Generalized arterial calcification of infancy-1 (GACI1)

Generalized arterial calcification of infancy (GACI) and autosomal recessive hypophosphatemia rickets type 2 (ARHR2) Awareness Day is recognized each year on Feb 1. This is a time for spreading awareness…

Continue Reading GACI/ARHR2 Awareness Day is February 1st: Spreading rare Disease Awareness

GACI Global’s Worldwide Walk

• Post author:James Moore
• Post published:September 25, 2022
• Post category:

GACI Global's Worldwide Walk September 25, 2022 The GACI/ARHR2 community, their family, friends, and supporters from around the world will be unified on one day, around one shared cause, when…

Continue Reading GACI Global’s Worldwide Walk

source: pixabay.com

Webinar: Hearing Loss, From GACI Global

• Post author:James Moore
• Post published:June 24, 2022
• Post category:Generalized arterial calcification of infancy-1 (GACI1)

On June 10, 2022, Patient Worthy partner GACI Global hosted an hour long webinar on the subject of hearing loss, featuring Dr. Karen Wilber. GACI Global is a nonprofit organization…

Continue Reading Webinar: Hearing Loss, From GACI Global

fernandozhiminaicela / Pixabay

Investigative Treatment for ENPP1 Deficiency Has Moved to Phase 1/2 Clinical Trial

• Post author:Trudy Horsting
• Post published:May 10, 2022
• Post category:Generalized arterial calcification of infancy-1 (GACI1)

Inozyme Pharma has recently announced that the first patient was dosed in its Phase 1/2 clinical trial of INZ-701 in adult patients with ABCC6 Deficiency and the second cohort in…

Continue Reading Investigative Treatment for ENPP1 Deficiency Has Moved to Phase 1/2 Clinical Trial